{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:32:05Z","timestamp":1793878325805,"version":"4.7.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["DA026859"],"award-info":[{"award-number":["DA026859"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"name":"VA Merit Review Program"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.pnpbp.2013.05.012","type":"journal-article","created":{"date-parts":[[2013,6,2]],"date-time":"2013-06-02T18:03:16Z","timestamp":1370196196000},"page":"223-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats"],"prefix":"10.1016","volume":"45","author":[{"given":"Therese A.","family":"Kosten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun Y.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berma M.","family":"Kinsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest D.","family":"Lykissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Orson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2013.05.012_bb0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1470-8744.1999.tb00904.x","article-title":"Design and synthesis of morphine-6-succinyl-bovine serum albumin hapten for vaccine development","volume":"30","author":"Akbarzadeh","year":"1999","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0010","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","article-title":"A novel bivalent morphine\/heroin vaccine that prevents relapse to heroin addiction in rodents","volume":"24","author":"Anton","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4161\/hv.5.4.7556","article-title":"Vaccines against morphine\/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors","volume":"5","author":"Anton","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0020","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1126\/science.178.4067.1290","article-title":"Evidence for active immunity to morphine in mice","volume":"22","author":"Berkowitz","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0025","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/252708a0","article-title":"Changes in heroin self-administration by a rhesus monkey after morphine immunisation","volume":"252","author":"Bonese","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0030","series-title":"The neuropharmacological basis of reward","first-page":"264","article-title":"Conditioned place preference as a measure of drug reward","author":"Carr","year":"1989"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0091-3057(99)00174-4","article-title":"Gender differences in the reinforcing properties of morphine","volume":"65","author":"Cicero","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0040","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/BF02245161","article-title":"Rate of increase of plasma drug level influences subjective response in humans","volume":"107","author":"deWit","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0045","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0019-2791(74)90079-2","article-title":"Critical antigenic determinants for production of antibody to distinguish morphine from heroin, codeine, and dextromethorphan","volume":"11","author":"Gross","year":"1974","journal-title":"Immunochemistry"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.biopsych.2009.08.031","article-title":"Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans","volume":"67","author":"Haney","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0055","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/clpt.2010.317","article-title":"Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic","volume":"89","author":"Hatsukami","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0060","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4049\/jimmunol.114.4.1363","article-title":"Delayed clearance of morphine from the circulation of rabbits immunized with morphine-6-hemisuccinate bovine serum albumin","volume":"114","author":"Hill","year":"1975","journal-title":"J Immunol"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0065","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0024-3205(83)90616-1","article-title":"Evidence from opiate binding studies that heroin acts through its metabolites","volume":"33","author":"Inturrisi","year":"1983","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0070","first-page":"281","article-title":"Buprenorphine: new treatment of opioid addiction in primary care","volume":"57","author":"Kahan","year":"2001","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1254\/jjp.24.165","article-title":"Antibodies to BSA conjugates of morphine derivatives: strict dependency of the immunological specificity on the hapten structure","volume":"24","author":"Koida","year":"1974","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0080","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/10550881003684798","article-title":"Pharmacotherapy in the treatment of addiction: methadone","volume":"29","author":"Kreek","year":"2010","journal-title":"J Addict Dis"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0085","first-page":"368","article-title":"Preparation and characterization of anti-morphine vaccine antibody","volume":"22","author":"Ma","year":"2006","journal-title":"Chinese Cell Mol Immunol"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0090","first-page":"1056","article-title":"Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans","volume":"299","author":"Marsch","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0095","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archgenpsychiatry.2009.128","article-title":"Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial","volume":"66","author":"Martell","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J069v21n03_01","article-title":"Optimizing long-term response to methadone maintenance treatment: a 152-week follow-up using higher-dose methadone","volume":"21","author":"Maxwell","year":"2002","journal-title":"J Addict Dis"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0105","series-title":"Guide for the care and use of laboratory animals","author":"NIH","year":"1996"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0091-3057(85)90051-6","article-title":"Toward understanding ethanol's capacity to be reinforcing: a conditioned place preference following injections of ethanol","volume":"22","author":"Reid","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0115","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0006-2952(01)00689-X","article-title":"m-Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monacetylmorphine compared to morphine","volume":"62","author":"Selley","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2011.281","article-title":"Vaccines against drug abuse","volume":"91","author":"Shen","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drugalcdep.2012.09.007","article-title":"A vaccine against methamphetamine attenuates its behavioral effects in mice","volume":"129","author":"Shen","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0130","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1073\/pnas.69.7.1835","article-title":"Coupling of a new, active morphine derivative to sepharose for affinity chromatography","volume":"69","author":"Simon","year":"1972","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0135","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656560903037168","article-title":"Opioid dependence treatment: options in pharmacotherapy","volume":"10","author":"Stotts","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0140","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1021\/jm200461m","article-title":"A vaccine strategy that induces protective immunity against heroin","volume":"54","author":"Stowe","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0145","series-title":"United Nations Office on Drugs and Crime: World Drug Report, Vol. Sales No. E.10.XI.13","author":"UNODC","year":"2010"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0150","first-page":"514","article-title":"Specificities of antibodies to morphine","volume":"180","author":"VanVunakis","year":"1972","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cpr.2009.10.006","article-title":"A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction","volume":"30","author":"Veilleux","year":"2010","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0165","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.176.4039.1143","article-title":"Morphine-3-succinyl-bovine serum albumin: an immunogenic hapten\u2013protein conjugate","volume":"176","author":"Wainer","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0160","first-page":"155","article-title":"A measurement of the specificities of antibodies to morphine-6-succinyl-BSA by competitive inhibition of 14 C\u2013morphine binding","volume":"30","author":"Wainer","year":"1973","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.pnpbp.2013.05.012_bb0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejphar.2004.01.003","article-title":"Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine","volume":"486","author":"Woolverton","year":"2004","journal-title":"Eur J Pharmacol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613001073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613001073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T15:23:40Z","timestamp":1715441020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584613001073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":34,"alternative-id":["S0278584613001073"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2013.05.012","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2013.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}